The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland) - Clinical characteristics of children recruited within the first 5 yr

Rheumatology

Volumn 45, Issue 10, 2006, Pages 1255-1260

  McCann, L J ^a   Juggins, A D ^b   Maillard, S M ^b   Wedderburn, L R ^b   Davidson, J E ^c   Murray, K J ^d   Pilkington, C A ^b  

^a ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^d PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

Author keywords

Dermatomyositis; Inflammatory; Juvenile; Myositis; Weakness

Indexed keywords

AZATHIOPRINE; CREATINE KINASE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LACTATE DEHYDROGENASE; METHOTREXATE; METHYLPREDNISOLONE; MUSCLE ENZYME; PREDNISOLONE; STEROID;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD MORTALITY; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DATA COLLECTION METHOD; DERMATOMYOSITIS; DISEASE ACTIVITY; DISEASE MARKER; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; INFLAMMATORY DISEASE; IRELAND; JUVENILE DERMATOMYOSITIS; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYALGIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RASH; REGISTER; TREATMENT OUTCOME; UNITED KINGDOM;

ADOLESCENT; BIOPSY; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DERMATOMYOSITIS; ELECTROMYOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; GREAT BRITAIN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; IRELAND; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE, SKELETAL; PATIENT SELECTION; REGISTRIES; RESPIRATORY FUNCTION TESTS; SKIN; TREATMENT OUTCOME;

EID: 33749639881     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel099     Document Type: Article

References (32)

1. Medsger TA Jr, Dawson WN Jr, Masi AT. The epidemiology of polymyositis. Am J Med 1970;48:715-23.
2. Mendez EP, Lipton R, Ramsey-Goldman R et al. US incidence of juvenile dermatomyositis, 1995-1998: Results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum 2003;49:300-5.
3. Oddis CV, Conte CG, Steen VD, Medsger TA. Incidence of polymyositis-dermatomyositis: A 20-year study of hospital diagnosed cases in Allegheny County, PA 1963-1982. J Rheumatol 1990; 17:1329-34.
4. Symmons DP, Sills JA, Davis SM. The incidence of juvenile dermatomyositis: Results from a nation-wide study. Br J Rheumatol 1995;34:732-6.
5. Pachman LM, Hayford JR, Chung A et al. Juvenile dermatomyositis at diagnosis: Clinical characteristics of 79 children. J Rheumatol 1998;25:1198-204.
6. Miller LC, Michael AF, Kim Y. Childhood dermatomyositis. Clinical course and long-term follow-up. Clin Pediatr (Phila) 1987;26:561-6.
7. Ramanan AV, Feldman BM. Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes. Rheum Dis Clin North Am 2002;28:833-57.
8. Sallum AM, Kiss MH, Sachetti S, Resende MB, Moutinho KC, Carvalho MD et al. Juvenile dermatomyositis: Clinical, laboratorial, histological, therapeutical and evolutive parameters of 35 patients. Arq Neuropsiquiatr 2002;60:889-99.
9. Hanissian AS, Masi AT, Pitner SE, Cape CC, Medsger TA. Polymyositis and dermatomyositis in children: An epidemiologic and clinical comparative analysis. J Rheumatol 1982;9:390-4.
10. Sullivan DB, Cassidy JT, Petty RE. Dermatomyositis in the pediatric patient. Arthritis Rheum 1977;20:327-31.
11. Florence JM, Pandya S, King WM et al. Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne's muscular dystrophy. Phys Ther 1992;72:115-22.
12. Lovell DJ, Lindsley CB, Rennebohm RM, Ballinger SH, Bowyer SL, Giannini EH et al. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): A quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Arthritis Rheum 1999;42:2213-9.
13. Feldman BM, Ayling-Campos A, Luy L, Stevens D, Silverman ED, Laxer RM. Measuring disability in juvenile dermatomyositis: Validity of the childhood health assessment questionnaire. J Rheumatol 1995;22:326-31.
14. Takken T, Elst E, Spermon N, Helders PJM, Prakken ABJ, van der Net J. The physiological and physical determinants of functional ability measures in children with juvenile dermatomyositis. Rheumatology 2003;42:591-5.
15. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
16. Bakeo AC, Clarke L. Child Population. The health of children and young people. Office for National Statistics, March 2004;Chapter 1.
17. Bitnum S, Daeschner CW Jr, Travis LB, Dodge WF, Hopps HC. Dermatomyositis. J Pediatr 1964;64:101-31.
18. Pachman LM, Cooke N. Juvenile dermatomyositis: A clinical and immunologic study. J Pediatr 1980;96:226-34.
19. Huber AM, Lang B, LeBlanc CM, Birdi N, Bolaria RK, Malleson P et al. Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum 2000;43:541-9.
20. Bohan A, Peter JB, Bowman RL, Pearson CM. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine 1977;56:255-86.
21. Brown V, Halkon E, Pilkington C et al. Revision of diagnostic criteria for juvenile dermatomyositis [abstract]. Clin Exp Rheumatol 2004;22: 528.
22. 2 relaxation time of thigh muscles in juvenile dermatomyositis. Rheumatology 2004;43:603-8.
23. Hernandez RJ, Sullivan DB, Chenevert TL, Keim DR. MR imaging in children with dermatomyositis: Musculoskeletal findings and correlation with clinical and laboratory findings. AJR Am J Roentgenol 1993;161:359-66.
24. Li CK, Varsani H, Holton JL, Gao B, Woo P, Wedderburn LR. MHC Class I overexpression on muscles in early juvenile dermatomyositis. J Rheumatol 2004;31:605-9.
25. Feldman BM, Reichlin M, Laxer RM, Targoff IN, Stein LD, Silverman ED. Clinical significance of specific autoantibodies in juvenile dermatomyositis. J Rheumatol 1996;23:1794-7.
26. Bowyer SL, Blane CE, Sullivan DB, Cassidy JT. Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification. J Pediatr 1983;103:882-8.
27. Taieb A, Guichard C, Salamon R, Maleville J. Prognosis in juvenile dermatopolymyositis: A cooperative retrospective study of 70 cases. Pediatr Dermatol 1985;2:275-81.
28. Spencer CH, Hanson V, Singsen BH, Bernstein BH, Kornreich HK, King KK. Course of treated juvenile dermatomyositis. J Pediatr 1984; 105:399-408.
29. Riley P, Maillard SM, Wedderburn LR, Woo P, Murray KJ, Pilkington CA. Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis. A review of efficacy and safety. Rheumatology 2004;43:491-6.
30. Olson NY, Lindsley CB. Adjunctive use of hydroxychloroquine in childhood dermatomyositis. J Rheumatol 1989;16:1545-7.
31. Miller JJ, III. Late progression in dermatomyositis in childhood. J Pediatr 1973;83:543-8.
32. Wedderburn LR, Li CK, Varsani H et al. An International Consensus working group to generate a scoring system for histological abnormality in juvenile dermatomyositis muscle biopsies. [abstract]. Clin Exp Rheumatol 2005;23(3): 143.